Product Information

Product NameIbandronate Sodium Monohydrate
Structure
Cas NO138926-19-9
Molecular Weight359.227
Molecular formulaC9H24NNaO8P2
Therap.Cat : Ibandronate Sodium is the sodium salt form of ibandronic acid, a synthetic nitrogen-containing bisphosphonate. Ibandronic acid inhibits farnesyl pyrophosphate synthase, resulting in a reduction in geranylgeranyl GTPase signaling proteins and apoptosis of osteoclasts. This agent increases bone mineral density, decreases bone remodeling, inhibits osteoclast-mediated bone resorption, and reduces metastases-related and corticosteroid-related bone pain.